Model innovation in Parkinson's disease drug development: linking Quantitative Systems Pharmacology to the patient voice

被引：0
|
作者：
Barrett, J.
Piccoli, B.
Muller, M.
Barrett, K.
Goncharov, D.
Kaddi, C.
Azer, K.
Romero, K.
Stephenson, D.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
287
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] Quantitative Systems Pharmacology for Rare Disease Drug Development
    Bai, Jane P. F.
    Wang, Jie
    Zhang, Yifei
    Wang, Lingshan
    Jiang, Xiling
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (09) : 2313 - 2320
  • [2] Quantitative analysis of voice in Parkinson's disease
    Silbergleit, A. K.
    Lewitt, P. A.
    Peterson, E. L.
    Gardner, G. M.
    MOVEMENT DISORDERS, 2015, 30 : S286 - S287
  • [3] A quantitative systems pharmacology model of colonic motility with applications in drug development
    Raibatak Das
    Lucia Wille
    Liming Zhang
    Chunlin Chen
    Wendy Winchester
    Jangir Selimkhanov
    Jill Wykosky
    Joshua F. Apgar
    John M. Burke
    Mark Rogge
    Fei Hua
    Majid Vakilynejad
    Journal of Pharmacokinetics and Pharmacodynamics, 2019, 46 : 485 - 498
  • [4] A quantitative systems pharmacology model of colonic motility with applications in drug development
    Das, Raibatak
    Wille, Lucia
    Zhang, Liming
    Chen, Chunlin
    Winchester, Wendy
    Selimkhanov, Jangir
    Wykosky, Jill
    Apgar, Joshua F.
    Burke, John M.
    Rogge, Mark
    Hua, Fei
    Vakilynejad, Majid
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2019, 46 (05) : 485 - 498
  • [5] A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease
    Roberts, Patrick
    Spiros, Athan
    Geerts, Hugo
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [6] A quantitative systems pharmacology model to describe the immunopathogenesis of inflammatory bowel disease and guide drug development decisions
    Ramakrishnan, Vidya
    Lu, Pinyi
    McBride, Jacqueline
    Fuh, Franklin
    Lekkerkerker, Annemarie
    Tang, Meina
    Leber, Andrew
    Hontecillas, Raquel
    Quartino, Angelica
    Jin, Jin Yan
    Bassaganya-Riera, Josep
    Ramanujan, Saroja
    Gadkar, Kapil
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S85 - S85
  • [7] Commentary: A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptomsin Parkinson's Disease
    Munoz, Patricia
    Segura-Aguilar, Juan
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [8] A Quantitative Systems Pharmacology Model of Colonic Motility to Aid Drug Discovery and Development
    Zhang Liming
    Raibatak, Das
    Lucia, Wille
    Chen Chunlin
    Jangir, Selimkhanov
    Jill, Wykosky
    Wendy, Winchester
    Cristina, Almansa
    John, Burke
    Fei, Hua
    Majid, Vakilynejad
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S71 - S71
  • [9] The FDA is listening: Integrating the voice of the patient in drug development for Parkinson's and Huntington's diseases
    Stephenson, D.
    Porter, A.
    Romero, K.
    Podskalny, G.
    Bastings, E.
    Dunn, B.
    Goldstein, S.
    Mullin, T.
    MOVEMENT DISORDERS, 2017, 32
  • [10] The Food and Drug Administration is Listening: Integrating the Voice of the Patient in Drug Development for Parkinson's and Huntington's Diseases
    Stephenson, Diane
    Romero, Klaus
    Podskalny, Gerald
    Bastings, Eric
    Dunn, Billy
    Goldstein, Susanne
    Mullin, Theresa
    NEUROTHERAPEUTICS, 2018, 15 (01) : 255 - 256
12345